However, in pathological conditions of psoriasis, it is still unclear whether the HMGB1‐TLR4‐IL‐23‐IL‐17A pathway may be involved in and contribute to the IL‐17A aggregation and its inflammatory reaction. Here, TLR4 is linked to psoriasis.